171 related articles for article (PubMed ID: 23222549)
1. LINE-1 methylation in peripheral blood and the risk of melanoma in melanoma-prone families with and without CDKN2A mutations.
Hyland PL; Burke LS; Pfeiffer RM; Mirabello L; Tucker MA; Goldstein AM; Yang XR
Melanoma Res; 2013 Feb; 23(1):55-60. PubMed ID: 23222549
[TBL] [Abstract][Full Text] [Related]
2. Blood DNA methylation, nevi number, and the risk of melanoma.
Pergoli L; Favero C; Pfeiffer RM; Tarantini L; Calista D; Cavalleri T; Angelici L; Consonni D; Bertazzi PA; Pesatori AC; Landi MT; Bollati V
Melanoma Res; 2014 Oct; 24(5):480-7. PubMed ID: 25026000
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations.
Liang XS; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM; Yang XR
Int J Cancer; 2012 May; 130(9):2062-6. PubMed ID: 21671477
[TBL] [Abstract][Full Text] [Related]
4. Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
Burke LS; Hyland PL; Pfeiffer RM; Prescott J; Wheeler W; Mirabello L; Savage SA; Burdette L; Yeager M; Chanock S; De Vivo I; Tucker MA; Goldstein AM; Yang XR
PLoS One; 2013; 8(8):e71121. PubMed ID: 23990928
[TBL] [Abstract][Full Text] [Related]
5. Constitutional promoter methylation and risk of familial melanoma.
Hyland PL; Burke LS; Pfeiffer RM; Rotunno M; Sun D; Patil P; Wu X; Tucker MA; Goldstein AM; Yang XR
Epigenetics; 2014 May; 9(5):685-92. PubMed ID: 24762620
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
Goldstein AM; Struewing JP; Chidambaram A; Fraser MC; Tucker MA
J Natl Cancer Inst; 2000 Jun; 92(12):1006-10. PubMed ID: 10861313
[TBL] [Abstract][Full Text] [Related]
7. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
[TBL] [Abstract][Full Text] [Related]
8. Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Pfeiffer RM; Wheeler W; Yeager M; Chanock S; Tucker MA; Goldstein AM
Int J Cancer; 2009 Dec; 125(12):2912-7. PubMed ID: 19626699
[TBL] [Abstract][Full Text] [Related]
9. LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis.
De Araújo ÉS; Kashiwabara AY; Achatz MI; Moredo LF; De Sá BC; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Melanoma Res; 2015 Apr; 25(2):173-7. PubMed ID: 25647737
[TBL] [Abstract][Full Text] [Related]
10. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
[TBL] [Abstract][Full Text] [Related]
11. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families.
Liang X; Pfeiffer RM; Li WQ; Brossard M; Burke LS; Wheeler W; Calista D; Fargnoli MC; Ghiorzo P; Peris K; Bianchi-Scarra G; Chaudru V; Zelenika D; Maeder D; Burdette L; Yeager M; Chanock S; Landi MT; Demenais F; Tucker MA; Goldstein AM; Yang XR
J Invest Dermatol; 2014 Feb; 134(2):481-487. PubMed ID: 23892592
[TBL] [Abstract][Full Text] [Related]
13. Constitutive mitochondrial DNA copy number in peripheral blood of melanoma families with and without
Hyland PL; Pfeiffer RM; Rotunno M; Hofmann JN; Liu CS; Cheng WL; Yuenger J; Lan Q; Tucker MA; Goldstein AM; Yang XR
J Carcinog Mutagen; 2014 Jun; 2014(Suppl 4):. PubMed ID: 25685612
[TBL] [Abstract][Full Text] [Related]
14. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
Goldstein AM; Martinez M; Tucker MA; Demenais F
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families.
Hocevar M; Avbelj M; Perić B; Zgajnar J; Besić N; Battelino T
Croat Med J; 2006 Dec; 47(6):851-4. PubMed ID: 17167857
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide DNA methylation profile of leukocytes from melanoma patients with and without CDKN2A mutations.
de Araújo É; Marchi FA; Rodrigues TC; Vieira HC; Kuasne H; Achatz MI; Moredo LF; de Sá BC; Duprat JP; Brentani HP; Rosenberg C; Carraro DM; Krepischi AC
Exp Mol Pathol; 2014 Dec; 97(3):425-32. PubMed ID: 25236571
[TBL] [Abstract][Full Text] [Related]
17. Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene.
Puig S; Ruiz A; Castel T; Volpini V; Malvehy J; Cardellach F; Lynch M; Mascaro JM; Estivill X
Hum Genet; 1997 Dec; 101(3):359-64. PubMed ID: 9439668
[TBL] [Abstract][Full Text] [Related]
18. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
Ruiz A; Puig S; Malvehy J; Lázaro C; Lynch M; Gimenez-Arnau AM; Puig L; Sánchez-Conejo J; Estivill X; Castel T
J Med Genet; 1999 Jun; 36(6):490-3. PubMed ID: 10874641
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy.
Casula M; Colombino M; Satta MP; Cossu A; Lissia A; Budroni M; Simeone E; Calemma R; Loddo C; Caracò C; Mozzillo N; Daponte A; Comella G; Canzanella S; Guida M; Castello G; Ascierto PA; Palmieri G;
Eur J Cancer; 2007 Jan; 43(1):137-43. PubMed ID: 17055252
[TBL] [Abstract][Full Text] [Related]
20. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]